Self-Management Program for Stroke
(IPASS-R Trial)
Trial Summary
What is the purpose of this trial?
The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Improving Participation after Stroke Self-Management Program (IPASS)?
Research shows that self-management programs can improve quality of life and self-confidence in managing health for stroke survivors. The IPASS program specifically aims to enhance participation in daily activities, which is crucial for long-term recovery and community reintegration after a stroke.12345
Is the Self-Management Program for Stroke safe for humans?
The available research does not specifically address the safety of the Self-Management Program for Stroke, but self-management programs in general are designed to support stroke survivors in managing their health and medications, which suggests they are generally safe and focused on improving quality of life.13678
How is the IPASS treatment different from other stroke treatments?
The IPASS treatment is unique because it focuses on improving participation in everyday life activities and community reintegration for stroke survivors, rather than just managing symptoms. It is a self-management program that enhances self-efficacy (confidence in managing one's condition) and is delivered in a group setting led by an occupational therapist and a lay person with stroke experience.1591011
Research Team
Anna E Boone, PhD, OTR/L
Principal Investigator
University of Missouri Occupational Therapy
Eligibility Criteria
This trial is for individuals aged 45-85 who had a mild or moderate stroke within the last 6 months, live in the community (not in skilled nursing facilities), can communicate in English, and can use videoconferencing with or without help. They should have finished any recommended inpatient rehab.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the IPASS-R intervention consisting of 6 weekly 90-minute sessions delivered via telehealth
Follow-up
Participants are monitored for self-efficacy, activity performance, and quality of life improvements
Treatment Details
Interventions
- Improving Participation after Stroke Self-Management Program (IPASS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
University of Washington
Collaborator
University of Illinois at Chicago
Collaborator